the fbi believes it was an industrial type strength bear spray and according to the documents this is the this canister they were using they sprayed in the faces of these three officers. one of them is officer sicknick. i ll read you just a part of the affidavit. it says, quote, officer sicknick, edwards and chapman standing in a few feet all react one by one. they immediately retreat from the line, bring their hands to their faces and rush to find water to wash out their eyes. this is one of the many, many assaults, that we saw that day on january 6th which the fbi says that people who were in this pro-trump mob used bear spray, pepper spray and other things to attack these officers. in this case officer sicknick went back to his office. he fell ill and was taken to the hospital. he died the following day. now, one of the things that s interesting is right now they re only charged these two men are only charged with assault on a federal officer. these are nine counts in
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits variable immunity responses among hosts based on symptom severity. Whether immunity in recovered individuals is effective for avoiding reinfection is poorly understood. Determination of immune memory status against SARS-CoV-2 helps identify reinfection risk and vaccine efficacy. Hence, after recovery from COVID-19, evaluation of protective effectiveness and durable immunity of prior disease could be significant. Recent reports described the dynamics of SARS-CoV-2 -specific humoral and cellular responses for more than six months in convalescent SARS-CoV-2 individuals. Given the current evidence, NK cell subpopulations, especially the memory-like NK cell subset, indicate a significant role in determining COVID-19 severity. Still, the information on the long-term NK cell immunity conferred by SARS-CoV-2 infection is scant. The evidence from vaccine clinical trials and observational studies indicates that hybrid natural/
and we know it s a safe thing to do and we know it s a safe thing to do and as you say, really good news for all the vaccines. if you remember how well people were being protected against hospitalisation and death in june, from two doses of either astrazeneca or pfizer, the fact all the six vaccines will provide a significant boost to the antibody immunity is really good news. 0bviously, immunity is really good news. obviously, there is a big difference between some of the vaccines for antibodies but the other really interesting thing from the trial is the studies we did on the t cells. we think the t cells, the cells in the body s blood that s responsible for immunological memory and the body responding as a result of the vaccine if you meet coronavirus again in the future, and although we clearly were not able to test for omicron yet in the study, double come later, but we looked at the
increasing transmissibility, like increasing tra nsmissibility, like delta increasing transmissibility, like delta and alpha variants, they are mutations which have been seen previously in other mutations which have some ability to overcome antibody immunity. what is important is at the moment until we get experimental evidence, it s very hard to tell. a single mutation tells us one thing but when they are together they could either work very well together or they might actually work negatively together, so that they might not actually be as bad as i think. until we get the experimental data, we have to assume the presence of these mutations and take the precautionary principle and be very wary. take the precautionary principle and be very wary- be very wary. anecdotally so far they report be very wary. anecdotally so far they report seem be very wary. anecdotally so far they report seem to be very wary. anecdotally so far they report seem to be - be very wary. anecdotally so fa